Previous studies have shown the high predictive value of MRI features for prostate cancer, Liu et al. used multiphase MRI features to predict P504s/P63 Immunohistochemical Expression and reached an AUC of 0.93, Qiao et al. also constructed a prediction model for Gleason grade group with T2 and DWI features, and the AUC of which was 0.92 [24, 25]. This evidence concerns the gene AMACR and prostate cancer.